Crescendo Bioscience logo

Crescendo Bioscience

Empowering rheumatologists with precise diagnostic tools for autoimmune and inflammatory disease management.

1001-5000 employees · est. 2002

VS
Magnisense logo

Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments

1 employees · est. 2003

Crescendo Bioscience is the older company (2002 vs 2003); Crescendo Bioscience is the larger of the two.

Side-by-Side Comparison

Crescendo Bioscience Magnisense
Founded
2002 older 2003
Headquarters
Not tracked yet Not tracked yet
Employees
1001-5000 larger 1
Industry
Biotechnology, Health Care Health Care
Funding Stage
Series D Series Unknown
Total Funding
$141.68M $11.70M
Funding Rounds
6 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Precision Medicine, Rheumatology, Autoimmune Diseases, Inflammatory Diseases, Diagnostic Tools, South San Francisco Cardiovascular Diagnostics, Emergency Diagnostics, MIAtek® Technology, Proprietary Diagnostic Instruments, Rapid Diagnostics, Diagnostic Tests, Cardiovascular Diseases, Innovation, Healthcare Solutions
Website
crescendobio.com magnisense.com
Crescendo Bioscience logo

About Crescendo Bioscience

Crescendo Bioscience, with the slogan "Empowering rheumatologists with precise diagnostic tools for autoimmune and inflammatory disease management," was founded in 2002 in South San Francisco, California. The company, originally known as Riley Genomics, Inc., focuses on creating diagnostic, prognost...

Magnisense logo

About Magnisense

Magnisense is a health care startup that has been making waves in the industry since its founding in 2003. The company's slogan "Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments" embodies its core mission. In...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Crescendo Bioscience and Magnisense — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Crescendo Bioscience and Magnisense — by email.

Frequently Asked Questions

Crescendo Bioscience — Empowering rheumatologists with precise diagnostic tools for autoimmune and inflammatory disease management.. Magnisense — Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Crescendo Bioscience has raised $141.68M while Magnisense has raised $11.70M.
Crescendo Bioscience and Magnisense operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Crescendo Bioscience with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy